In this respect, the observed increased sHLA-G plasma levels and titer of anti-U94 antibodies in SSc subjects might be considered a marker for disease severity and suggest the involvement of the virus and U94 in the development of the disease. This evidence concerns the gene SNORD94 and systemic sclerosis.